All Relations between Moyamoya Disease and mmd

Publication Sentence Publish Date Extraction Date Species
Nathan A Shlobin, Steven C Hoffman, Jeffrey R Clark, Rebecca Y Du, Sandi La. Clinical Usefulness of Genetic Testing For Patients with Moyamoya Disease: A Systematic Review. World neurosurgery. vol 152. 2021-09-16. PMID:34098142. the effect of genetic factors on presentation and outcomes of moyamoya disease (mmd) is unclear. 2021-09-16 2023-08-13 Not clear
R Mertens, M Graupera, H Gerhardt, A Bersano, E Tournier-Lasserve, M A Mensah, S Mundlos, P Vajkocz. The Genetic Basis of Moyamoya Disease. Translational stroke research. 2021-09-16. PMID:34529262. moyamoya disease (mmd) is a rare cerebrovascular disease characterized by progressive spontaneous bilateral occlusion of the intracranial internal cerebral arteries (ica) and their major branches with compensatory capillary collaterals resembling a "puff of smoke" (japanese: moyamoya) on cerebral angiography. 2021-09-16 2023-08-13 Not clear
Jun Sun, Zhang-Yu Li, Chuan Chen, Cong Ling, Hao Li, Hui Wan. Postoperative neovascularization, cerebral hemodynamics, and clinical prognosis between combined and indirect bypass revascularization procedures in hemorrhagic moyamoya disease. Clinical neurology and neurosurgery. vol 208. 2021-09-15. PMID:34419781. we evaluated what few studies emphasized the postoperative collateral formation and cerebral hemodynamics of hemorrhagic moyamoya disease (mmd). 2021-09-15 2023-08-13 Not clear
Muneaki Matsuo, Satomi Nadanaka, Minami Soga, Taku Sugiyama, Shota Serigano, Kenjiro Shimano, Fumio Ichinose, Takuji Nakamura, Toshiyuki Maeda, Kiyohiro Houkin, Takumi Era, Hiroshi Kitagaw. Vulnerability to shear stress caused by altered peri-endothelial matrix is a key feature of Moyamoya disease. Scientific reports. vol 11. issue 1. 2021-09-14. PMID:33452387. moyamoya disease (mmd) is characterized by progressive bilateral stenotic changes in the terminal portion of the internal carotid arteries. 2021-09-14 2023-08-13 Not clear
Kei Kitakami, Yoshitaka Kubo, Masahiro Yabuki, Daisuke Oomori, Tatsuhiko Takahashi, Suguru Igarashi, Shunrou Fujiwara, Kenji Yoshida, Masakazu Kobayashi, Kazunori Terasaki, Kuniaki Ogasawar. Five-Year Outcomes of Medical Management Alone for Adult Patients with Ischemic Moyamoya Disease without Cerebral Misery Perfusion. Cerebrovascular diseases (Basel, Switzerland). 2021-09-14. PMID:34518462. no clear guidelines for treating adult patients with ischemic moyamoya disease (mmd) without cerebral hemodynamic compromise such as misery perfusion have been established. 2021-09-14 2023-08-13 Not clear
S Yang, X Wang, W Liao, L Li, Z Tan, L Zhu, P Hu, X Cui, W Xin. High-resolution MRI of the vessel wall helps to distinguish moyamoya disease from atherosclerotic moyamoya syndrome. Clinical radiology. vol 76. issue 5. 2021-09-08. PMID:33583567. to evaluate the value of high-resolution magnetic resonance imaging of the vessel wall (vwi) for differentiating moyamoya disease (mmd) from atherosclerotic moyamoya syndrome (as-mms). 2021-09-08 2023-08-13 Not clear
Jiabin Su, Wei Ni, Baofeng Yang, Weiping Xiao, Xinjie Gao, Heng Yang, Yanjiang Li, Yu Lei, Hanqiang Jiang, He Wang, Yuxiang Gu, Ying Ma. Preliminary Study on the Application of Ultrahigh Field Magnetic Resonance in Moyamoya Disease. Oxidative medicine and cellular longevity. vol 2021. 2021-09-07. PMID:33520085. magnetic resonance imaging (mri) is widely used for the evaluation of moyamoya disease (mmd). 2021-09-07 2023-08-13 Not clear
Santiago R Unda, Aldana M Antoniazzi, Raphael Miller, Daniel Klyde, Kainaat Javed, Rose Fluss, Ryan Holland, Rafael De la Garza Ramos, Neil Haranhalli, David J Altschu. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. vol 30. issue 9. 2021-09-07. PMID:34247053. ischemic stroke and hemorrhagic stroke are the most common sequelae of the moyamoya variants [moyamoya disease (mmd) and syndrome (mms)]. 2021-09-07 2023-08-13 Not clear
Ziping Han, Lingzhi Li, Ping Liu, Yuyou Huang, Sijia Zhang, Guangwen Li, Fangfang Li, Haiping Zhao, Zhen Tao, Rongliang Wang, Qingfeng Ma, Yumin Lu. Metabolic Adjustments by LncRNAs in Peripheral Neutrophils Partly Account for the Complete Compensation of Asymptomatic MMD Patients. CNS & neurological disorders drug targets. vol 19. issue 4. 2021-09-06. PMID:32552656. due to the recent development of non-invasive examinations, more asymptomatic patients with moyamoya disease (mmd) have been diagnosed than ever. 2021-09-06 2023-08-13 Not clear
Xiao Ren, Ling-Ling Yao, Jin-Xiu Pan, Jun-Shi Zhang, Lin Mei, Yong-Gang Wang, Wen-Cheng Xion. Linking cortical astrocytic neogenin deficiency to the development of Moyamoya disease-like vasculopathy. Neurobiology of disease. vol 154. 2021-09-02. PMID:33775822. moyamoya-like vasculopathy, the "puff of smoke"-like small vessels in the brain, is initially identified in patients with moyamoya disease (mmd), a rare cerebrovascular disease, and later found in patients with various types of neurological conditions, including down syndrome, stroke, and vascular dementia. 2021-09-02 2023-08-13 mouse
Chun-Hsin Teng, I-Hsiao Yang, Meng-Ni Wu, Ping-Song Cho. Posterior reversible encephalopathy syndrome (PRES) in a patient with moyamoya disease: A case report. Medicine. vol 100. issue 31. 2021-09-02. PMID:34397851. moyamoya disease (mmd) and posterior reversible encephalopathy syndrome (pres) share similar pathophysiological characteristics of endothelial dysfunction and impaired cerebral autoregulation. 2021-09-02 2023-08-13 Not clear
Markus K H Wiedmann, Chris Davidoff, Anna Lo Presti, Wei Ni, Jong Kook Rhim, Mary Simons, Marcus A Stoodle. Treatment of ruptured aneurysms of the choroidal collateral system in moyamoya disease: a systematic review and data analysis. Journal of neurosurgery. 2021-08-27. PMID:34450582. moyamoya disease (mmd) is a chronic, progressive steno-occlusive condition of the distal internal carotid arteries of unknown etiology. 2021-08-27 2023-08-13 Not clear
Priyanka Sarkar, Kavitha Thirumuruga. In silico explanation for the causalities of deleterious RNF213 SNPs in Moyamoya disease and insulin resistance. Computational biology and chemistry. vol 92. 2021-08-23. PMID:33930741. moyamoya disease (mmd), a cerebrovascular disorder caused by the rnf213 gene, is a cerebrovascular, neurological disorder leading to ischemic strokes. 2021-08-23 2023-08-13 Not clear
Lanxin Du, Hanyu Jiang, Jin Li, Ting Duan, Chenyun Zhou, Feng Ya. Imaging methods for surgical revascularization in patients with moyamoya disease: an updated review. Neurosurgical review. 2021-08-21. PMID:34417671. neuroimaging is crucial in moyamoya disease (mmd) for neurosurgeons, during pre-surgical planning and intraoperative navigation not only to maximize the success rate of surgery, but also to minimize postsurgical neurological deficits in patients. 2021-08-21 2023-08-13 Not clear
Adam J Kundishora, Samuel T Peters, Amélie Pinard, Daniel Duran, Shreyas Panchagnula, Tanyeri Barak, Danielle F Miyagishima, Weilai Dong, Hannah Smith, Jack Ocken, Ashley Dunbar, Carol Nelson-Williams, Shozeb Haider, Rebecca L Walker, Boyang Li, Hongyu Zhao, Dean Thumkeo, Arnaud Marlier, Phan Q Duy, Nicholas S Diab, Benjamin C Reeves, Stephanie M Robert, Nanthiya Sujijantarat, Amber N Stratman, Yi-Hsien Chen, Shujuan Zhao, Isabelle Roszko, Qiongshi Lu, Bo Zhang, Shrikant Mane, Christopher Castaldi, Francesc López-Giráldez, James R Knight, Michael J Bamshad, Deborah A Nickerson, Daniel H Geschwind, Shih-Shan Lang Chen, Phillip B Storm, Michael L Diluna, Charles C Matouk, Darren B Orbach, Seth L Alper, Edward R Smith, Richard P Lifton, Murat Gunel, Dianna M Milewicz, Sheng Chih Jin, Kristopher T Kahl. DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease. JAMA neurology. vol 78. issue 8. 2021-08-13. PMID:34125151. moyamoya disease (mmd), a progressive vasculopathy leading to narrowing and ultimate occlusion of the intracranial internal carotid arteries, is a cause of childhood stroke. 2021-08-13 2023-08-13 Not clear
Yue Wang, Luping Yang, Xiaotong Wang, Fanxin Zeng, Kaili Zhang, Qian Zhang, Mengwei Liu, Shan Liu, Mengke Shang, Qian Li, Yuetian Yang, Man Liang, Wanyang Li. Meta-analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease. European journal of neurology. vol 28. issue 3. 2021-08-12. PMID:33175469. the aim of this meta-analysis study was to assess the predictive effects of rnf213 p.r4810k on phenotype in moyamoya disease (mmd). 2021-08-12 2023-08-13 Not clear
Changshui Wang, Cuilian Sun, Yueshu Zhao, Huimin Song, Zhengyou Li, Feng Jin, Changmeng Cu. RNF213 gene silencing upregulates transforming growth factor β1 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease. Experimental and therapeutic medicine. vol 22. issue 3. 2021-08-11. PMID:34373710. moyamoya disease (mmd) is a chronic and progressive cerebrovascular occlusion disease, the precise etiology of which is poorly understood. 2021-08-11 2023-08-13 rat
Xiaofeng Deng, Peicong Ge, Rong Wang, Dong Zhang, Jizong Zhao, Yan Zhan. Risk factors for postoperative ischemic complications in pediatric moyamoya disease. BMC neurology. vol 21. issue 1. 2021-08-10. PMID:34157993. ischemic events are the most common postoperative complication in bypass surgery for moyamoya disease (mmd), but the risk factors for pediatric mmd remain unclear. 2021-08-10 2023-08-13 Not clear
Moinay Kim, Wonhyoung Park, Yeongu Chung, Si Un Lee, Jung Cheol Park, Do Hoon Kwon, Jae Sung Ahn, Seungjoo Le. Development and validation of a risk scoring model for postoperative adult moyamoya disease. Journal of neurosurgery. vol 134. issue 5. 2021-08-09. PMID:32384266. the current grading system for moyamoya disease (mmd) is focused on angiographic studies with limited clinical application. 2021-08-09 2023-08-13 Not clear
Katsuma Iwaki, Soh Takagishi, Koichi Arimura, Masaharu Murata, Toru Chiba, Ataru Nishimura, Nice Ren, Koji Iihar. A Novel Hyperspectral Imaging System for Intraoperative Prediction of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Patients with Moyamoya Disease. Cerebrovascular diseases (Basel, Switzerland). vol 50. issue 2. 2021-08-09. PMID:33596563. postoperative cerebral hyperperfusion syndrome (chs) may occur after superficial temporal artery (sta)-middle cerebral artery (mca) bypass for moyamoya disease (mmd). 2021-08-09 2023-08-13 Not clear